LENZ
LENZ Therapeutics
LENZ
LENZ
78 hedge funds and large institutions have $445M invested in LENZ Therapeutics in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
5.95% less ownership
Funds ownership: 74.08% → 68.13% (-6%)
Holders
78
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$10.7M | |
| 2 | +$3.86M | |
| 3 | +$3.31M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$2.55M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$1.94M |
Top Sellers
| 1 | -$20.7M | |
| 2 | -$4.74M | |
| 3 | -$2.54M | |
| 4 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$1.74M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$1.03M |